Two in three adults in England are overweight or obese - and 26 per cent of us have learned all we know about treatments like ...

A new study has found that Mounjaro may not only be good at treating diabetes, but could actually help prevent the disease.

Ozempic and Wegovy also belong to the GLP-1 category. It is understood that Ms McGowan, who had worked as a nurse at University Hospital Monklands in Airdrie for more than 30 years, had purchased a ...

GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart ...

Both Wegovy and Mounjaro have now been approved for treating obesity on the NHS, and the Government has announced ambitious plans to offer them to thousands of people who are unable to work with ...

As the battle against obesity and diabetes heats up, two new superstars are entering the ring in Spain - Mounjaro (also known ...

Ozempic, Wegovy, Mounjaro, and similar drugs have exploded in popularity over the last few years. The medications are used to treat obesity and type 2 diabetes—and, as researchers are ...

Novo Nordisk, the drug company that makes Ozempic and Wegovy, and Eli Lilly, the manufacturer of Mounjaro and Zepbound, do not deny that their drugs cause side effects, most often involving GI ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

The NHS rollout of appetite suppressing injections has been thrown into doubt after what is believed to be the first confirmed death linked to the controversial drugs ...

A trial, targeted at people living with obesity from Britain to Puerto Rico, is the first head-to-head comparison of the weight-loss effects of the two blockbuster slimming jabs ...